• FOLLOW US
Video Player
  • Email
  • share

Ebola vaccine 'highly effective' trial should continue

July 31 -- Merck & Co.'s vaccine for Ebola is "highly effective," according to an interim analysis from a panel of experts who recommended that a late-stage trial should continue. Bloomberg's Drew Armstrong reports on "Market Makers."

http://www.wtsp.com/video/4389794716001/1/Ebola-vaccine-highly-effective-trial-should-continue http://videos.usatoday.net/Brightcove2/29906170001/2015/07/29906170001_4389554285001_thumb-it424d4kHSFU.jpg?pubId=29906170001 Ebola vaccine 'highly effective' trial should continue July 31 -- Merck & Co.'s vaccine for Ebola is "highly effective," according to an interim analysis from a panel of experts who recommended that a late-stage trial should continue. Bloomberg's Drew Armstrong reports on "Market Makers." Bloomberg 02:54

Next Up

    

More Videos